We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$104B
AUM Growth
+$9.45B
Cap. Flow
+$9.9B
Cap. Flow %
9.52%
Top 10 Hldgs %
28.08%
Holding
8,130
New
449
Increased
3,536
Reduced
3,324
Closed
388

Sector Composition

Rank Sector Weight
1 Healthcare 5.43%
2 Energy 4.72%
3 Technology 4.42%
4 Financials 3.4%
5 Consumer Discretionary 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALDR
6401
DELISTED
Alder Biopharmaceuticals
ALDR
$18K ﹤0.01%
1,550
+1,374
+781% +$20.8K
BNCL
6402
DELISTED
Beneficial Bancorp, Inc.
BNCL
$18K ﹤0.01%
1,630
-1,036
-39% -$12.6K
STBZ
6403
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$18K ﹤0.01%
1,127
-1,267
-53% -$21.1K
HSNI
6404
CALL
DELISTED
HSN, Inc.
HSNI
$18K ﹤0.01%
300
-1,700
-85% -$100K
CYNO
6405
DELISTED
Cynosure, Inc. Class A
CYNO
$18K ﹤0.01%
807
+331
+70% +$7.28K
IGTE
6406
PUT
DELISTED
IGATE CORPORATION
IGTE
$18K ﹤0.01%
500
-200
-29% -$7.43K
KBIO
6407
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$18K ﹤0.01%
2,193
-99
-4% -$1.36K
NWLIA
6408
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
$18K ﹤0.01%
73
-1,917
-96% -$473K
ABCB icon
6409
Ameris Bancorp
ABCB
$5.92B
$17K ﹤0.01%
839
-5,216
-86% -$116K
AMC icon
6410
AMC Entertainment Holdings
AMC
$2.14B
$17K ﹤0.01%
74
+37
+100% +$8.72K
ENOV icon
6411
CALL
Enovis
ENOV
$1.42B
$17K ﹤0.01%
174
-639
-79% -$71.8K
FIBK icon
6412
First Interstate BancSystem
FIBK
$3.62B
$17K ﹤0.01%
637
+312
+96% +$8.37K
FN icon
6413
Fabrinet
FN
$18.8B
$17K ﹤0.01%
1,222
-227,722
-99% -$3.97M
GFF icon
6414
CALL
Griffon
GFF
$4.84B
$17K ﹤0.01%
1,500
HVT icon
6415
Haverty Furniture Companies
HVT
$443M
$17K ﹤0.01%
802
+360
+81% +$8.49K
ICMB icon
6416
Investcorp Credit Management BDC
ICMB
$12.5M
$17K ﹤0.01%
+1,309
New +$17.9K
INSG icon
6417
Inseego
INSG
$84.9M
$17K ﹤0.01%
564
+70
+14% +$1.56K
KELYA icon
6418
Kelly Services Class A
KELYA
$536M
$17K ﹤0.01%
1,193
+475
+66% +$7.86K
LCTX icon
6419
Lineage Cell Therapeutics
LCTX
$283M
$17K ﹤0.01%
6,789
-10,340
-60% -$24.9K
MIDU icon
6420
PUT
Direxion Daily Mid Cap Bull 3X ETF
MIDU
$79.2M
$17K ﹤0.01%
1,000
-25,500
-96% -$464K
MITT
6421
TPG Mortgage Investment Trust
MITT
$214M
$17K ﹤0.01%
332
-1,562
-82% -$88.9K
MLKN icon
6422
CALL
MillerKnoll
MLKN
$1.62B
$17K ﹤0.01%
+600
New +$18K
MMSI icon
6423
Merit Medical Systems
MMSI
$5.44B
$17K ﹤0.01%
1,503
+747
+99% +$9.91K
MYE icon
6424
Myers Industries
MYE
$1.21B
$17K ﹤0.01%
957
-5,142
-84% -$97.9K
PKE icon
6425
Park Aerospace
PKE
$815M
$17K ﹤0.01%
733
+365
+99% +$10.3K

Similar funds

Barclays's Q3 2014 Portfolio in Review

As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.

By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.9% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.

  • Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
  • Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
  • Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
  • Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
  • Barclays opened 449 new positions and closed 388 in Q3 2014.
  • Barclays's portfolio value rose 10% quarter-over-quarter to $104B.

Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.